Kibum Kim, PhD

kk2.jpg

Title: Research Assistant Professor

Contact

L. S. Skaggs Pharmacy Institute, Room 4929
Phone: (801) 585-6380
Email: kibum.kim@pharm.utah.edu

Profile

Kibum Kim is a Research Assistant Professor in the Department of Pharmacotherapy and at the Pharmacotherapy Outcomes Research Center, University of Utah. He graduated from University of Illinois at Chicago with his PhD in Pharmacy, specialized in pharmacoeconomics and health outcomes research. Prior to working at University of Utah, he interned at Abbvie, Inc., Takeda Pharmaceuticals, and eMax Health Company where he assisted multiple market access and real-world outcome projects. He also had years’ practical experience from community pharmacies. Dr. Kim’s research interest includes contemporary trends in medication utilization, outcome analysis using sophisticated statistical approach and model-based cost-effectiveness analysis.

During his career, Dr. Kim has published his researches in clinical and economic outcomes of treatment options for diabetes, cardiovascular disorders, and oncology. His recent studies focus on the clinical utility of molecular diagnostics, therapeutic drug monitoring, and precision medicine.

Education

  • 2016-2018 Post-Doctoral Fellow, Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, Utah
  • 2011-2016  PhD in Pharmacy specialized in pharmacoeconomics and outcomes research, University of Illinois at Chicago, Chicago, Illinois     
  • 2006-2008  Master of Science in Pharmacy specialized in Pharmacokinetics and Pharmacodynamics, Catholic University of Daegu, Gyeongbuk Province, South Korea
  • 2002-2006  Bachelor in Pharmacy, Catholic University of Daegu, Gyeongbuk Province, South Korea

Research Interests

  • Utility of precision medicine and molecular diagnostic testing
  • Utilization and outcomes of antiplatelet therapy and anti-coagulation management
  • Glycemic control associated with anti-diabetic agent use and concurrent medication to prevent patient from long-term complications
  • Resource utilization and healthcare cost across multiple chronic conditions
  • Research methods in health outcomes research using real-world databases

Selected Publications

  • Kim K, Magness J, Thurman R, Nelson R, Chang A, Brixner DI, Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients. J Manag Care Spec Pharm. 2018 Dec;24(12):1250-1259
  • Kim K, Lee TA, Ardati AK, Didomenico RJ, Touchette DR, Walton SM, Comparison of Six-Month Costs between Oral Anti-Platelet Agents following Acute Coronary Syndrome. J Manag Care Spec Pharm. 2018 Aug;24(8):800-812

  • Oderda GM, Lawless GD, Wright GC, Nussbaum SR, Elder R, Kim K, Brixner DI. The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs. Per Med. 2018 Jul; 15(4): 291-301 
  • Kim K, Cox N, Witt D, Diagnosis of stroke associated with overutilization of thrombophilia testing. Thrombosis Research. 2017;157:139-141 
  • Kim K, Lee TA, Ardati AK, Didomenico RJ, Touchette DR, Walton SM, Comparative Effectiveness of Oral Antiplatelet agents in Patients with Acute Coronary Syndrome. Pharmacotherapy. 2017: 37(8): 887-881

Upcoming Events

View Calendar

IT Services

CPCSS - COMPUTER SUPPORT REQUEST

COMPUTER SUPPORT REQUEST